# Safety and Dosing Evaluation of REG1 Anticoagulation System

> **NCT00113997** · PHASE1 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 106 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** REG1

## Key facts

- **NCT ID:** NCT00113997
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 106 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113997, "Safety and Dosing Evaluation of REG1 Anticoagulation System". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00113997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*